Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors
Molecules · 2025
DOI: 10.3390/molecules30122641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Srinivasulu Cherukupalli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Norwegian University of Science and Technology (NTNU), Høgskoleringen 5, NO-7491 Trondheim, Norway. Hauptthemen laut MEDLINE: Triazoles, Pyrimidines, Pyrroles, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Trond Mohn Foundation.
Abstract (Originalsprache)
6-Aryl-7H-pyrrolo[2,3-d]pyrimidin-4-amines have promising properties as colony-stimulating factor 1 receptor (CSF1R) inhibitors. Inspired by these antagonists, two series of 1,2,3-triazole analogues (28 compounds) were synthesized and evaluated as CSF1R inhibitors. Enzymatic IC50 profiling showed that 27 of the 28 derivatives had lower IC50 than the reference drug PLX-3397. Three derivatives displayed CSF1R Ba/F3 cellular IC50 well below 1 µM. Profiling of the most promising triazole analogue (compound 27a) toward a panel of kinases reveals a high selectivity for CSF1R with respect to its family kinases, but 27a also inhibits ABL, SRC, and YES kinases. Molecular docking of 27a toward two CSF1R X-ray structures identified two different ligand-inverted binding poses, which triggers interest for further investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Norwegian University of Science and Technology (NTNU), Høgskoleringen 5, NO-7491 Trondheim, Norway.
- Lead Discovery Center GmbH (LDC), Otto-Hahn-Strasse 15, 44227 Dortmund, Germany.
- Department of Material Science, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.
ORCID-Profile: Srinivasulu Cherukupalli, Jan Eickhoff, Peter Habenberger, Anke Unger, Bård Helge Hoff
Förderung
- Trond Mohn Foundation
Zitieren
APA
Cherukupalli, S., Eickhoff, J., Degenhart, C., Habenberger, P., Unger, A., Hoff, B. H., & Sundby, E. (2025). Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors. Molecules. https://doi.org/10.3390/molecules30122641
Vancouver
Cherukupalli S, Eickhoff J, Degenhart C, Habenberger P, Unger A, Hoff BH, et al. Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors. Molecules. 2025. doi:10.3390/molecules30122641
BibTeX
@article{Cherukupalli2025,
author = {Cherukupalli, Srinivasulu and Eickhoff, Jan and Degenhart, Carsten and Habenberger, Peter and Unger, Anke and Hoff, Bård Helge and Sundby, Eirik},
title = {Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30122641}
}
EUVIMED